According to report publish a new market research report on the “Computational Biology Market: Global Size, Trends, Competitive, Historical and Forecast Analysis, 2020-2025”

A recent report on Computational Biology Market provides a detailed analysis on the industry size, revenue forecasts and geographical landscape pertaining to this business space. Additionally, the report highlights primary obstacles and latest growth trends accepted by key players that form a part of the competitive spectrum of this business.

Increasing research & development activities on healthcare throughout the world is driving the computational biology market.

Global Computational Biology market is valued at USD 4.40 billion in 2019 and expected to reach USD 11.306 billion by 2025 with the CAGR of 20.72% over the forecast period.

The study of biological, ecological, behavioral and social systems with the development and application of data-analytical & theoretical methods, mathematical modeling and computational simulation techniques is all together called computational biology. It comprises subjects such as foundation in biology, applied mathematics, statistics, biochemistry, biophysics, molecular biology, genetics, genomics, computer science and evolution. It is different from biological computing as the latter is subfield of computer science and computer engineering in which bioengineering and biology is applied to build computers. But computational biology is similar to bioinformatics, which uses computers to store and process biological data.

The regions covered in the global computational biology market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of clinical decision support system is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

On June 18, 2019, BeiGene, Ltd. and SpringWorks Therapeutics, Inc., announced the creation of MapKure, LLC, a newly created entity that is jointly owned by BeiGene and SpringWorks. MapKure aims to develop BGB-3245, an investigational, oral, selective small molecule inhibitor of monomer and dimer forms of activating B-RAF mutations including V600 BRAF mutations, non-V600 B-RAF mutations, and RAF fusions through the help of computational biology process. These mutations and fusions have been recognized in a number of solid tumours to be drivers of cancer growth, including in non-small cell lung cancer, colorectal cancer, thyroid cancer, and brain tumours.

Technological development in big data application, advantages of computing biological data in research activities, need of speeding up research activities due to increasing prevalence of chronic diseases such as cancer and innovation of artificial intelligence are the major factors driving the computational biology market. The increasing demand of computational biology is due to the presence of opportunities for computational explorations for patterns and integration across rich available data sets. For example, in development of RNA sequencing, bioinformatics process is used in designing statistical framework for analyzing data and generating a gene expression matrix. The published single-cell RNA seq. papers in the literature have increased fivefold in past 5 years, with many of those papers have significant support from computational biologists which shows the effectiveness of computational biology in research activities which increases the demand of this market. Use of machine learning in computational biology is starting to become more and more important as it is being applied in genomics, proteomics and cancer detections for efficient result from research activities as well as for effective diagnosis. However, the main restraining factor for this market is the need for computational biologists to collaborate thoroughly with experimentalists and clinicians across the biomedical spectrum to conclude and finding results in any research activities. Growing funding initiatives from government bodies is expected to help in the computational biology market growth in forecast period.

Global Computational Biology Market Regional Analysis –

North America is currently dominating the computational biology market with highest market share due to government funding for genetic based studies, increase in public private partnerships and collaboration between pharmaceutical industries and academies. For example, US government has spent about USD 430 million on synthetic biology research, where Department of Energy (DOE) invested majority of this research since 2005. The field is still not explored that much as it is scattered among small groups, across both US and EU. The US is more developed region for synthetic and system biology in terms of activity and networking among scientific community. But, in case of Europe, they have spent approximately USD 160 million on synthetic biology research which is new sector of computational biology with slight decrease in funding shows the overall computational biology market being invested by both of these regions and is expected to have growing investment scenario due to emergence of disease such as novel corona virus. In case of Asia-Pacific region, it will have high growth rate due to population based studies, foreign investment and government initiatives. For example, the Synthetic and Systems Biology is at a nascent stage in India and The institutions involved in the research activity in this area comprises CSIR (Council of Scientific & Industrial Research) Laboratories, IISc (Indian Institute of Science), NCBS (National Centre for Biological Sciences), IIT-Kharagpur, Bose Institute, University of Kerala and a couple of companies with government of India support.

We publish market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students.